An open-label study on long-term outcomes of bosentan for treating ulcers in thromboangiitis obliterans (Buerger's disease)
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference7 articles.
1. Diagnostic criteria of Buerger's disease;Shionoya;Int J Cardiol,1998
2. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist;Korn;Arthritis Rheum,2004
3. Successful treatment of systemic sclerosis digital ulcers and pulmonary arterial hypertension with endothelin receptor antagonist bosentan;Humbert;Rheumatology,2003
4. Successful treatment of severe Raynaud's phenomenon with bosentan in four patients with systemic sclerosis;Ramos-Casals;Rheumatology,2004
5. Bosentan for treatment of active digital ulcers in patients with systemic sclerosis;Launay;Presse Med,2006
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Milestones in thromboangiitis obliterans: a position paper of the VAS-European independent foundation in angiology/vascular medicine;International Angiology;2021-10
2. The Management of Ischemic Limb in Thromboangiitis Obliterans (Buerger’s Disease);Indian Journal of Surgery;2021-03-27
3. Stem Cell Therapy for Thromboangiitis Obliterans (Buerger’s Disease);Processes;2020-11-04
4. Successful Fat Grafting in a Patient With Thromboangiitis Obliterans;Advances in Skin & Wound Care;2019-12
5. Pathogenesis of thromboangiitis obliterans: Gene polymorphism and immunoregulation of human vascular endothelial cells;Atherosclerosis;2017-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3